Antenatal corticosteroids (ANS) are the major intervention to decrease respiratory distress
syndrome and mortality from premature birth and are standard of care. The use of ANS is …

Antenatal corticosteroids (ACS) are standard of care for women at risk of preterm delivery,
although choice of drug, dose or route have not been systematically evaluated. Further, ACS …

We review the history of antenatal corticosteroid therapy (ACS) and present recent
experimental data to demonstrate that this, one of the pillars of perinatal care, has been …

Landmark early work has led to the nearly universal use of antenatal corticosteroids to
accelerate fetal lung maturity with pregnancies complicated by impending preterm birth …

Antenatal corticosteroids (ACS) administration to pregnant women for threatened preterm
labor is standard obstetric care to reduce neonatal respiratory distress syndrome and the …

Abstract Treatment with antenatal corticosteroids (ACS) is standard of care for women at risk
of preterm birth between 24 and 34 weeks' gestation. ACS are increasingly used for other …

Background The use of antenatal corticosteroids (ACS) in low-resource environments is
sporadic. Further, drug choice, dose, and route of ACS are not optimized. We report the …

A single course of prenatal corticosteroid therapy has been shown to accelerate fetal lung
maturation when premature delivery is imminent. 1–3 This therapy reduces morbidity and …

Background The intramuscular administration of antenatal steroids to women at risk of
preterm delivery achieves high maternal and fetal plasma steroid concentrations, which are …

National Institute of Child Health and Development consensus panels held in 1994 and
2000 concluded that both betamethasone and dexamethasone accelerated fetal lung …